Forum Πρωτοβάθμιας Φροντίδας Υγείας
ΠΦΥ -Εκπαίδευση => Αποσπάσματα από τον έντυπο & ηλεκτρονικό τύπο => Μήνυμα ξεκίνησε από: Argirios Argiriou στις 21 Σεπτεμβρίου 2024, 10:11:05
-
Journal Watch, Sep 12, 2024
More Data on the Association of GLP-1 Agonists with Severe Depression
Christopher W. Goodman, MD, reviewing Ueda P et al. JAMA Intern Med 2024 Sep 3 Wadden TA et al. JAMA Intern Med 2024 Sep 3 Schoretsanitis G et al. JAMA Netw Open 2024 Aug
These drugs appear to be safe for patients without mental health diagnoses, but questions remain.
https://www.jwatch.org/na57915/2024/09/12/more-data-association-glp-1-agonists-with-severe?query=topic_diabetes&jwd=000100032085&jspc=GP&cid=DM2360803_Non_Subscriber&bid=-1761015041 (https://www.jwatch.org/na57915/2024/09/12/more-data-association-glp-1-agonists-with-severe?query=topic_diabetes&jwd=000100032085&jspc=GP&cid=DM2360803_Non_Subscriber&bid=-1761015041)
-
Journal Watch Aug 29, 2024
Will GLP-1–Receptor Agonists Break the (Medicare) Bank?
Daniel D. Dressler, MD, MSc, MHM, FACP, reviewing Chaitoff A et al. Ann Intern Med 2024 Aug 27
https://www.jwatch.org/na57864/2024/08/29/will-glp-1-receptor-agonists-break-medicare-bank?query=topic_diabetes&jwd=000100032085&jspc=GP&cid=DM2360803_Non_Subscriber&bid=-1761015041 (https://www.jwatch.org/na57864/2024/08/29/will-glp-1-receptor-agonists-break-medicare-bank?query=topic_diabetes&jwd=000100032085&jspc=GP&cid=DM2360803_Non_Subscriber&bid=-1761015041)